---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025568"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:52:05.277503+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma to present at NobleCon 21 on Dec 3, 2025

## Summary
- CFO/co-CEO James Martin to give Company overview and clinical progress update.
- Presentation at Noble Capital Markets' 21st Emerging Growth Equity Conference on Dec 3, 2025 at 10:00 AM ET.
- Conference held at Florida Atlantic University in Boca Raton, Florida.
- Webcast will be archived for 90 days on Cocrystal's website starting Dec 4.

## SEC filing metadata
- accession: 0001493152-25-025568
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/0001493152-25-025568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315225025568/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025568
- JSON: https://secwatch.observer/filing/0001493152-25-025568.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.